PinX1: A sought-after major tumor suppressor at human chromosome 8p23

Oncotarget

Volumn 2, Issue 10, 2011, Pages 810-819

  Zhou, Xiao Zhen ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chromosome 8p23; Chromosome instabilty; LOH; PinX1; Telomerase; Telomerase inhibitor; Telomere; Tumor suppressor

Indexed keywords

NUCLEAR PROTEIN; PINX1 PROTEIN, HUMAN; PINX1 PROTEIN, MOUSE; TELOMERASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; ANIMAL; ARTICLE; BREAST TUMOR; CHROMOSOMAL INSTABILITY; CHROMOSOME 8; DRUG ANTAGONISM; FEMALE; GENETICS; HETEROZYGOSITY LOSS; HUMAN; MOUSE; PATHOLOGY; PHYSIOLOGY;

ADULT; ANIMALS; BREAST NEOPLASMS; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MICE; NUCLEAR PROTEINS; TELOMERASE; TUMOR SUPPRESSOR PROTEINS;

EID: 84865865358     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.339     Document Type: Article

References (115)

1. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983, 305(5937):779-784.
2. Foulkes WD Inherited susceptibility to common cancers. N Engl J Med 2008, 359(20):2143-2153.
3. Nathanson KL, Wooster R, Weber BL Breast cancer genetics: what we know and what we need. Nat Med 2001, 7(5):552-556.
4. Hodgson SV, Morrison PJ, Irving M Breast cancer genetics: unsolved questions and open perspectives in an expanding clinical practice. Am J Med Genet C Semin Med Genet 2004, 129(1):56-64.
5. Hartman AR, Ford JM BRCA1 and p53: compensatory roles in DNA repair. J Mol Med 2003, 81(11):700-707.
6. Keen JC, Davidson NE The biology of breast carcinoma. Cancer 2003, 97(3 Suppl):825-833.
7. Moynahan ME The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. Oncogene 2002, 21(58):8994-9007.
8. Buchholz TA, Weil MM, Story MD, Strom EA, Brock WA, McNeese MD Tumor suppressor genes and breast cancer. Radiat Oncol Investig 1999, 7(2):55-65.
9. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 1992, 52(19):5368-5372.
10. Becker SA, Zhou YZ, Slagle BL Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res 1996, 56(21):5092-5097.
11. Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997, 14(24):2927-2933.
12. Pineau P, Nagai H, Prigent S, Wei Y, Gyapay G, Weissenbach J, Tiollais P, Buendia MA, Dejean A Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma. Oncogene 1999, 18(20):3127-3134.
13. Liao C, Zhao M, Song H, Uchida K, Yokoyama KK, Li T Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma. Hepatology 2000, 32(4 Pt 1):721-727.
14. Wong N, Lai P, Pang E, Fung LF, Sheng Z, Wong V, Wang W, Hayashi Y, Perlman E, Yuna S et al Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin Cancer Res 2000, 6(10):4000-4009.
15. Yokota T, Yoshimoto M, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y, Emi M Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1. Cancer 1999, 85(2):447-452.
16. Wang JC, Radford DM, Holt MS, Helms C, Goate A, Brandt W, Parik M, Phillips NJ, DeSchryver K, Schuh ME et al Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23. Genomics 1999, 60(1):1-11.
17. Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL, Holcomb IN, Massa HF, Glogovac J, Li CI et al Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res 2004, 64(23):8541-8549.
18. Bhattacharya N, Chunder N, Basu D, Roy A, Mandal S, Majumder J, Roychowdhury S, Panda CK Three discrete areas within the chromosomal 8p21.3-23 region are associated with the development of breast carcinoma of Indian patients. Exp Mol Pathol 2004, 76(3):264-271.
19. Varma G, Varma R, Huang H, Pryshchepava A, Groth J, Fleming D, Nowak NJ, McQuaid D, Conroy J, Mahoney M et al Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York. Br J Cancer 2005, 93(6):699-708.
20. Kishimoto Y, Shiota G, Wada K, Kitano M, Nakamoto K, Kamisaki Y, Suou T, Itoh T, Kawasaki H Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma. J Cancer Res Clin Oncol 1996, 122(10):585-589.
21. Lai J, Flanagan J, Phillips WA, Chenevix-Trench G, Arnold J Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer. Br J Cancer 2003, 88(2):270-276.
22. Baffa R, Santoro R, Bullrich F, Mandes B, Ishii H, Croce CM Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer. Clin Cancer Res 2000, 6(4):1372-1377.
23. Gustafson CE, Wilson PJ, Lukeis R, Baker E, Woollatt E, Annab L, Hawke L, Barrett JC, Chenevix-Trench G Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer. Cancer Res 1996, 56(22):5238-5245.
24. Sunwoo JB, Sun PC, Gupta VK, Schmidt AP, El-Mofty S, Scholnick SB Localization of a putative tumor suppressor gene in the sub-telomeric region of chromosome 8p. Oncogene 1999, 18(16):2651-2655.
25. Wong MP, Lam WK, Wang E, Chiu SW, Lam CL, Chung LP Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance. Cancer Res 2002, 62(15):4464-4468.
26. Kondo T, Oue N, Mitani Y, Kuniyasu H, Noguchi T, Kuraoka K, Nakayama H, Yasui W Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. Oncogene 2005, 24(1):157-164.
27. Kahng YS, Lee YS, Kim BK, Park WS, Lee JY, Kang CS Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma. J Gastroenterol Hepatol 2003, 18(4):430-436.
28. Hamaguchi M, Meth JL, von Klitzing C, Wei W, Esposito D, Rodgers L, Walsh T, Welcsh P, King MC, Wigler MH DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc Natl Acad Sci U S A 2002, 99(21):13647-13652.
29. Ishii H, Vecchione A, Murakumo Y, Baldassarre G, Numata S, Trapasso F, Alder H, Baffa R, Croce CM FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis. Proc Natl Acad Sci U S A 2001, 98(18):10374-10379.
30. Ishii H, Baffa R, Numata SI, Murakumo Y, Rattan S, Inoue H, Mori M, Fidanza V, Alder H, Croce CM The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc Natl Acad Sci U S A 1999, 96(7):3928-3933.
31. Kirk KE, Harmon BP, Reichardt IK, Sedat JW, Blackburn EH Block in anaphase chromosome separation caused by a telomerase template mutation. Science 1997, 275:1478-1481.
32. van Steensel B, Smogorzewska A, de Lange T TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92(3):401-413.
33. Samper E, Goytisolo FA, Slijepcevic P, van Buul PP, Blasco MA Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep 2000, 1(3):244-252.
34. Rudolph KL, Millard M, Bosenberg MW, DePinho RA Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 2001, 28(2):155-159.
35. Gisselsson D, Jonson T, Petersen A, Strombeck B, Dal Cin P, Hoglund M, Mitelman F, Mertens F, Mandahl N Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A 2001, 98(22):12683-12688.
36. Stewenius Y, Gorunova L, Jonson T, Larsson N, Hoglund M, Mandahl N, Mertens F, Mitelman F, Gisselsson D Structural and numerical chromosome changes in colon cancer develop through telomere-mediated anaphase bridges, not through mitotic multipolarity. Proc Natl Acad Sci U S A 2005, 102(15):5541-5546.
37. Stewenius Y, Jin Y, Ora I, de Kraker J, Bras J, Frigyesi A, Alumets J, Sandstedt B, Meeker AK, Gisselsson D Defective chromosome segregation and telomere dysfunction in aggressive Wilms' tumors. Clin Cancer Res 2007, 13(22 Pt 1):6593-6602.
38. Artandi SE, DePinho RA Telomeres and telomerase in cancer. Carcinogenesis 2010, 31(1):9-18.
39. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91(1):25-34.
40. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, DePinho RA p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999, 97(4):527-538.
41. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, DePinho RA Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96(5):701-712.
42. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA Telomere dysfunction promotes nonreciprocal translocations and epithelial cancers in mice. Nature 2000, 406(6796):641-645.
43. O'Hagan RC, Chang S, Maser RS, Mohan R, Artandi SE, Chin L, DePinho RA Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2002, 2(2):149-155.
44. Martinez P, Siegl-Cachedenier I, Flores JM, Blasco MA MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres. Aging Cell 2009, 8(1):2-17.
45. Blanco R, Munoz P, Flores JM, Klatt P, Blasco MA Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. Genes Dev 2007, 21(2):206-220.
46. Greenberg RA, Chin L, Femino A, Lee KH, Gottlieb GJ, Singer RH, Greider CW, DePinho RA Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 1999, 97(4):515-525.
47. Gonzalez-Suarez E, Samper E, Flores JM, Blasco MA Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 2000, 26(1):114-117.
48. Feldser DM, Greider CW Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 2007, 11(5):461-469.
49. Cosme-Blanco W, Shen MF, Lazar AJ, Pathak S, Lozano G, Multani AS, Chang S Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep 2007, 8(5):497-503.
50. Jaskelioff M, Song W, Xia J, Liu C, Kramer J, Koido S, Gendler SJ, Calderwood SK, Gong J Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. Oncogene 2009, 28(48):4225-4236.
51. Oh BK, Kim H, Park YN, Yoo JE, Choi J, Kim KS, Lee JJ, Park C High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis. Lab Invest 2008, 88(2):144-152.
52. Gertler R, Doll D, Maak M, Feith M, Rosenberg R Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma. Cancer 2008, 112(10):2173-2180.
53. Nurnberg P, Thiel G, Weber F, Epplen JT Changes of telomere lengths in human intracranial tumours. Hum Genet 1993, 91(2):190-192.
54. Bisoffi M, Heaphy CM, Griffith JK Telomeres: prognostic markers for solid tumors. Int J Cancer 2006, 119(10):2255-2260.
55. Garcia-Aranda C, de Juan C, Diaz-Lopez A, Sanchez-Pernaute A, Torres AJ, Diaz-Rubio E, Balibrea JL, Benito M, Iniesta P Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma. Cancer 2006, 106(3):541-551.
56. Ohali A, Avigad S, Ash S, Goshen Y, Luria D, Feinmesser M, Zaizov R, Yaniv I Telomere length is a prognostic factor in neuroblastoma. Cancer 2006, 107(6):1391-1399.
57. Gertler R, Rosenberg R, Stricker D, Friederichs J, Hoos A, Werner M, Ulm K, Holzmann B, Nekarda H, Siewert JR Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol 2004, 22(10):1807-1814.
58. Svenson U, Nordfjall K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, Henriksson R, Lenner P, Roos G Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res 2008, 68(10):3618-3623.
59. de Lange T Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005, 19(18):2100-2110.
60. Wu L, Multani AS, He H, Cosme-Blanco W, Deng Y, Deng JM, Bachilo O, Pathak S, Tahara H, Bailey SM et al Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 2006, 126(1):49-62.
61. Baumann P, Cech TR Pot1, the putative telomere endbinding protein in fission yeast and humans. Science 2001, 292(5519):1171-1175.
62. Hockemeyer D, Daniels JP, Takai H, de Lange T Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres. Cell 2006, 126(1):63-77.
63. van Steensel B, de Lange T Control of telomere length by the human telomeric protein Trf1. Nature 1997, 385:740-743.
64. Smith S, Giriat I, Schmitt A, de Lange T Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998, 282(5393):1484-1487.
65. Kim SH, Kaminker P, Campisi J TIN2, a new regulator of telomere length in human cells. Nat Genet 1999, 23(4):405-412.
66. Zhou XZ, Lu KP The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell 2001, 107:347-359.
67. Loayza D, De Lange T POT1 as a terminal transducer of TRF1 telomere length control. Nature 2003, 423(6943):1013-1018.
68. Lu KP, Hanes SD, Hunter T A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380(6574):544-547.
69. Shen M, Haggblom C, Vogt M, Hunter T, Lu KP Characterization and cell cycle regulation of related human telomeric proteins Pin2 and TRF1 suggest a role in mitosis. Proc Natl Acad Sci USA 1997, 94:13618-13623.
70. Lu KP, Zhou XZ The prolyl isomerase Pin1: a pivotal new twist in phosphorylation signalling and human disease. Nat Rev Mol Cell Biol 2007, 8:904-916.
71. Kishi K, Lu KP A critical role for Pin2/TRF1 in ATMdependent regulation: Inhibition of Pin2/TRF1 function complements telomere shortening, the radiosensitivity and G2/M checkpoint defect of Ataxia-Telangiectasia cells. J Biol Chem 2002, 277:7420-7429.
72. Nakamura M, Zhou XZ, Kishi S, Kosugi I, Tsutsui Y, Lu KP A specific interaction between the telomeric protein Pin2/TRF1 and the mitotic spindle. Curr Biol 2001, 11:1512-1516.
73. Zhu Q, Meng L, Hsu JK, Lin T, Teishima J, Tsai RY GNL3L stabilizes the TRF1 complex and promotes mitotic transition. J Cell Biol 2009, 185(5):827-839.
74. Lee TH, Tun-Kyi A, Shi R, Lim J, Soohoo C, Finn G, Balastik M, Pastorino L, Wulf G, Zhou XZ et al Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance. Nat Cell Biol 2009, 11(1):97-105.
75. Zhou XZ, Perrem K, Lu KP Role of Pin2/TRF1 in telomere maintenance and cell cycle control. J Cell Biochem 2003, 89:19-37.
76. Lee TH, Perrem K, Harper JW, Lu KP, Zhou XZ F-box protein Fbx4 targets Pin2/TRF1 for ubiquitin-mediated degradation and regulates telomere maintenance. J Biol Chem 2006, 281:759-768.
77. Banik SS, Counter CM Characterization of interactions between PinX1 and human telomerase subunits hTERT and hTR. J Biol Chem 2004, 279(50):51745-51748.
78. Lin J, Blackburn EH Nucleolar protein PinX1p regulates telomerase by sequestering its protein catalytic subunit in an inactive complex lacking telomerase RNA. Genes Dev 2004, 18(4):387-396.
79. Oh BK, Yoon SM, Lee CH, Park YN Rat homolog of PinX1 is a nucleolar protein involved in the regulation of telomere length. Gene 2007, 400(1-2):35-43.
80. Sun C, Wu Z, Jia F, Wang Y, Li T, Zhao M Identification of zebrafish LPTS: a gene with similarities to human LPTS/PinX1 that inhibits telomerase activity. Gene 2008, 420(1):90-98.
81. Soohoo CY, Shi R, Lee TH, Huang P, Lu KP, Zhou XZ Telomerase inhibitor PINX1 provides a link between TRF1 and telomerase to prevent telomere elongation. J Biol Chem 2011, 286:3894-3906.
82. Zhou XZ, Huang P, Shi R, Lee TH, Lu G, Zhang Z, Bronson R, Lu KP The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability. J Clin Invest 2011, 121:1266-1282.
83. Liao C, Zhao MJ, Zhao J, Jia D, Song H, Li ZP Overexpression of LPTS-L in hepatocellular carcinoma cell line SMMC-7721 induces crisis. World J Gastroenterol 2002, 8(6):1050-1052.
84. Kelleher C, Kurth I, Lingner J Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro. Mol Cell Biol 2005, 25(2):808-818.
85. Chong L, van SB, Broccoli D, Erdjument BH, Hanish J, Tempst P, de Lange T A human telomeric protein. Science 1995, 270(5242):1663-1667.
86. Ancelin K, Brunori M, Bauwens S, Koering CE, Brun C, Ricoul M, Pommier JP, Sabatier L, Gilson E Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol Cell Biol 2002, 22(10):3474-3487.
87. Hawkins GA, Chang BL, Zheng SL, Isaacs SD, Wiley KE, Bleecker ER, Walsh PC, Meyers DA, Xu J, Isaacs WB Mutational analysis of PINX1 in hereditary prostate cancer. Prostate 2004, 60(4):298-302.
88. Zhao Y, Sfeir AJ, Zou Y, Buseman CM, Chow TT, Shay JW, Wright WE Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell 2009, 138(3):463-475.
89. Wu X, Pandolfi PP Mouse models for multistep tumorigenesis. Trends Cell Biol 2001, 11(11):S2-9.
90. Hakem R, Mak TW Animal models of tumor-suppressor genes. Annnu Rev Genet 2001, 35:209-241.
91. Else T, Trovato A, Kim AC, Wu Y, Ferguson DO, Kuick RD, Lucas PC, Hammer GD Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis. Cancer Cell 2009, 15(6):465-476.
92. Cayuela ML, Flores JM, Blasco MA The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression. EMBO Rep 2005, 6(3):268-274.
93. Soohoo CY, Shi R, Lee TH, Huang P, Lu KP, Zhou XZ Telomerase inhibitor PINX1 provides a link between TRF1 and telomerase to prevent telomere elongation. J Biol Chem 2010:Nov 30. [Epub ahead of print].
94. Miller MC, Collins K The Tetrahymena p80/p95 complex is required for proper telomere length maintenance and micronuclear genome stability. Mol Cell 2000, 6(4):827-837.
95. Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, Manola JB, Ganesan S, Lansdorp PM, Collins K, Hahn WC The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci U S A 2005, 102(23):8222-8227.
96. Sharma GG, Gupta A, Wang H, Scherthan H, Dhar S, Gandhi V, Iliakis G, Shay JW, Young CS, Pandita TK hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 2003, 22(1):131-146.
97. Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, Chang W, Meng Z, Cheung P, Ji H et al Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 2009, 460(7251):66-72.
98. Guglielmi B, Werner M The yeast homolog of human PinX1 is involved in rRNA and small nucleolar RNA maturation, not in telomere elongation inhibition. J Biol Chem 2002, 277(38):35712-35719.
99. Yuan K, Li N, Jiang K, Zhu T, Huo Y, Wang C, Lu J, Shaw A, Thomas K, Zhang J et al PinX1 is a novel microtubulebinding protein essential for accurate chromosome segregation. J Biol Chem 2009, 284(34):23072-23082.
100. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279(5349):349-352.
101. Vaziri H, Benchimol S Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998, 8(5):279-282.
102. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998, 396(6706):84-88.
103. Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, Sahin E, Kost-Alimova M, Protopopov A, Cadinanos J et al Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011, 469(7328):102-106.
104. Gonzalez-Suarez E, Samper E, Ramirez A, Flores JM, Martin-Caballero J, Jorcano JL, Blasco MA Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. Embo J 2001, 20(11):2619-2630.
105. Artandi SE, Alson S, Tietze MK, Sharpless NE, Ye S, Greenberg RA, Castrillon DH, Horner JW, Weiler SR, Carrasco RD et al Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci U S A 2002, 99(12):8191-8196.
106. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, Modha P, Mizuno H, Brooks MW, Fleming M, Zimonjic DB et al Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci U S A 2002, 99(20):12606-12611.
107. Gonzalez-Suarez E, Flores JM, Blasco MA Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development. Mol Cell Biol 2002, 22(20):7291-7301.
108. Canela A, Martin-Caballero J, Flores JM, Blasco MA Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice. Mol Cell Biol 2004, 24(10):4275-4293.
109. Gonzalez-Suarez E, Geserick C, Flores JM, Blasco MA Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene 2005, 24(13):2256-2270.
110. Cristofari G, Lingner J Telomere length homeostasis requires that telomerase levels are limiting. Embo J 2006, 25(3):565-574.
111. Chen G, Da L, Wang H, Xu Y, Sun C, Wang L, Zhao J, Zhang F, Feng J, Wang Y et al HIV-Tat-mediated delivery of an LPTS functional fragment inhibits telomerase activity and tumorigenicity of hepatoma cells. Gastroenterology 2011, 140(1):332-343.
112. Zhang L, Jiang Y, Zheng Y, Zeng Y, Yang Z, Huang G, Liu D, Gao M, Shen X, Wu G et al Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1. Leukemia 2011, 25(2):331-340.
113. Wang HB, Wang WQ, Wang XW, Sun YG, Zhou G, Yang SM, Fan DC PinX1 gene transfection enhances the sensitivity of gastric carcinoma cell line to 5-fluorouracil. Hepatogastroenterology 2011, 58(106):682-686.
114. Harley CB Telomerase and cancer therapeutics. Nat Rev Cancer 2008, 8(3):167-179.
115. Joseph I, Tressler R, Bassett E, Harley C, Buseman CM, Pattamatta P, Wright WE, Shay JW, Go NF The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. Cancer Res 2010, 70(22):9494-9504.